Isoray Inc Stock Revenue
IsoRay Inc fundamentals help investors to digest information that contributes to IsoRay's financial success or failures. It also enables traders to predict the movement of IsoRay Stock. The fundamental analysis module provides a way to measure IsoRay's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to IsoRay stock.
IsoRay |
IsoRay Inc Company Revenue Analysis
IsoRay's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current IsoRay Revenue | 10.79 M |
Most of IsoRay's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, IsoRay Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
CompetitionBased on the latest financial disclosure, IsoRay Inc reported 10.79 M of revenue. This is 99.86% lower than that of the Biotechnology sector and 99.58% lower than that of the Health Care industry. The revenue for all United States stocks is 99.89% higher than that of the company.
IsoRay Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses IsoRay's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of IsoRay could also be used in its relative valuation, which is a method of valuing IsoRay by comparing valuation metrics of similar companies.IsoRay is currently under evaluation in revenue category among its peers.
IsoRay Fundamentals
| Return On Equity | -0.17 | |||
| Return On Asset | -0.11 | |||
| Profit Margin | (1.16) % | |||
| Operating Margin | (1.21) % | |||
| Current Valuation | (11.02 M) | |||
| Shares Outstanding | 278.66 M | |||
| Shares Owned By Insiders | 0.76 % | |||
| Shares Owned By Institutions | 6.18 % | |||
| Number Of Shares Shorted | 409.25 K | |||
| Price To Earning | (5.00) X | |||
| Price To Book | 0.74 X | |||
| Price To Sales | 4.14 X | |||
| Revenue | 10.79 M | |||
| Gross Profit | 4.62 M | |||
| EBITDA | (6.86 M) | |||
| Net Income | (7.27 M) | |||
| Cash And Equivalents | 55.89 M | |||
| Cash Per Share | 0.39 X | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 26.18 X | |||
| Book Value Per Share | 0.39 X | |||
| Cash Flow From Operations | (7.71 M) | |||
| Short Ratio | 1.70 X | |||
| Earnings Per Share | (0.04) X | |||
| Target Price | 1.0 | |||
| Number Of Employees | 66 | |||
| Beta | 1.49 | |||
| Market Capitalization | 107 M | |||
| Total Asset | 64.44 M | |||
| Retained Earnings | (82.05 M) | |||
| Working Capital | 12.54 M | |||
| Current Asset | 13.63 M | |||
| Current Liabilities | 1.09 M | |||
| Z Score | -1.4 | |||
| Net Asset | 64.44 M |
Pair Trading with IsoRay
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if IsoRay position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IsoRay will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to UnitedHealth Group could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace UnitedHealth Group when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back UnitedHealth Group - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling UnitedHealth Group Incorporated to buy it.
The correlation of UnitedHealth Group is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as UnitedHealth Group moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if UnitedHealth Group moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for UnitedHealth Group can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Consideration for investing in IsoRay Stock
If you are still planning to invest in IsoRay Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the IsoRay's history and understand the potential risks before investing.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |